Fibrinolysis Shutdown in Severe COVID-19: Highly Prevalent but not Independently Predictive of Thrombosis or Poorer Outcomes.
作者信息
Littlejohn James, Vasovic Ljiljana V, Cushing Melissa M, Barie Philip S
机构信息
New York, NY.
出版信息
J Am Coll Surg. 2022 Jan 1;234(1):97-98. doi: 10.1097/XCS.0000000000000007.
PMID:35213468
Abstract
摘要
相似文献
1
Fibrinolysis Shutdown in Severe COVID-19: Highly Prevalent but not Independently Predictive of Thrombosis or Poorer Outcomes.重症 COVID-19 中的纤维蛋白溶解功能关闭：高度普遍但并非血栓形成或不良结局的独立预测因素。
J Am Coll Surg. 2022 Jan 1;234(1):97-98. doi: 10.1097/XCS.0000000000000007.
2
Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19?重症新型冠状病毒肺炎（COVID-19）是发生了高纤维蛋白溶解还是纤维蛋白溶解关闭？
Thromb Res. 2022 Feb;210:1-3. doi: 10.1016/j.thromres.2021.12.012. Epub 2021 Dec 20.
3
Fibrinolysis Shutdown in COVID-19-Associated Coagulopathy: A Crosstalk among Immunity, Coagulation, and Specialists in Medicine and Surgery.新冠病毒相关凝血病中的纤维蛋白溶解功能关闭：免疫、凝血以及医学与外科专家之间的相互作用
J Am Coll Surg. 2021 Jun;232(6):1003-1006. doi: 10.1016/j.jamcollsurg.2021.03.003. Epub 2021 Apr 1.
4
Fibrinolysis Shutdown and Thrombosis in a COVID-19 ICU.新冠重症监护病房中的纤维蛋白溶解关闭与血栓形成
Shock. 2021 Jun 1;55(6):845-846. doi: 10.1097/SHK.0000000000001666.
5
Fibrinolysis Shutdown in COVID-19: Clinical Manifestations, Molecular Mechanisms, and Therapeutic Implications.COVID-19 中的纤维蛋白溶解关闭：临床特征、分子机制和治疗意义。
J Am Coll Surg. 2021 Jun;232(6):995-1003. doi: 10.1016/j.jamcollsurg.2021.02.019. Epub 2021 Mar 22.
6
Thrombosis and Coagulopathy in COVID-19.新型冠状病毒肺炎中的血栓与出凝血障碍。
Curr Probl Cardiol. 2021 Mar;46(3):100742. doi: 10.1016/j.cpcardiol.2020.100742. Epub 2020 Nov 2.
7
Fibrinolytic Shutdown in COVID-19 Is Likely a Misnomer.新冠病毒感染中纤维蛋白溶解功能关闭可能是个误称。
Shock. 2021 Jun 1;55(6):844-845. doi: 10.1097/SHK.0000000000001665.
8
Incidence and Outcomes of Thrombotic Events in Symptomatic Patients With COVID-19.有症状的COVID-19患者血栓形成事件的发生率和结局
Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):545-547. doi: 10.1161/ATVBAHA.120.315304. Epub 2020 Sep 29.
9
Thromboaspiration and fibrinolysis infusion for portomesenteric thrombosis after AstraZeneca COVID-19 vaccine administration.阿斯利康新冠疫苗接种后门静脉肠系膜血栓形成的血栓抽吸和纤维蛋白溶解输注治疗
Intensive Care Med. 2021 Sep;47(9):1034-1036. doi: 10.1007/s00134-021-06458-3. Epub 2021 Jun 16.
10
Fibrinolysis Resistance: A Potential Mechanism Underlying COVID-19 Coagulopathy.纤维蛋白溶解抵抗：新冠病毒感染相关凝血障碍的潜在机制
Thromb Haemost. 2020 Sep;120(9):1343-1345. doi: 10.1055/s-0040-1713637. Epub 2020 Jul 9.
Zotero 插件